To explore BRD9 upregulation in leukemia, we analyzed epigenetic marks in BRD9 regulatory regions of AML patient’s cohort compared with normal progenitors and differentiated cells; unfortunately, we did not highlight significative differences between them. The gene discussed is BRD9; the disease is leukemia.